Pam McKay

5.3k total citations
77 papers, 1.4k citations indexed

About

Pam McKay is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Pam McKay has authored 77 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pathology and Forensic Medicine, 27 papers in Oncology and 23 papers in Genetics. Recurrent topics in Pam McKay's work include Lymphoma Diagnosis and Treatment (50 papers), CNS Lymphoma Diagnosis and Treatment (18 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Pam McKay is often cited by papers focused on Lymphoma Diagnosis and Treatment (50 papers), CNS Lymphoma Diagnosis and Treatment (18 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Pam McKay collaborates with scholars based in United Kingdom, United States and Australia. Pam McKay's co-authors include Kate Cwynarski, Mike Leach, Kim Linton, Barbara J. Bain, J. D. Williams, Gerald A. Coles, B. Hulme, Elizabeth A. Sanders, I. Cavill and E. McGregor and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Pam McKay

69 papers receiving 1.4k citations

Peers

Countries citing papers authored by Pam McKay

Since Specialization

Citations

This map shows the geographic impact of Pam McKay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pam McKay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pam McKay more than expected).

Fields of papers citing papers by Pam McKay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pam McKay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pam McKay. The network helps show where Pam McKay may publish in the future.

Co-authorship network of co-authors of Pam McKay

This figure shows the co-authorship network connecting the top 25 collaborators of Pam McKay. A scholar is included among the top collaborators of Pam McKay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pam McKay. Pam McKay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	An international real‐world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators	British Journal of Haematology	Catherine Tang, Mandeep S. Sagoo et al.	0
2	IBCL-675: Bexobrutideg (NX-5948), a Novel Bruton’s Tyrosine Kinase (BTK) Degrader, Shows High Clinical Activity and Tolerable Safety in an Ongoing Phase 1a/b Study in Patients With Waldenström Macroglobulinemia (WM)	Clinical Lymphoma Myeloma & Leukemia	Dima El‐Sharkawi, David Lewis et al.	0
3	Management of relapsed or refractory large B‐cell lymphoma: A British Society for Haematology Guideline	British Journal of Haematology	Sridhar Chaganti, Christopher P. Fox et al.	2
4	Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patients	Clinical Science	Alasdair Henderson, J. Andrew McClure et al.	0
5	Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper	British Journal of Haematology	Nimish Shah, Andrew Chadwick et al.	0
6	The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline	British Journal of Haematology	Christopher P. Fox, Sridhar Chaganti et al.	8
7	‘ACOPP’ chemotherapy for older and less fit patients with Hodgkin lymphoma—a multicentre, retrospective study	Hematological Oncology	Matthew R. Wilson, Emma Haynes et al.	0
8	Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)	British Journal of Haematology	Adam Gibb, Sarah Pirrie et al.	25
9	Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory Follicular Lymphoma	Blood	Franck Morschhauser, Hervé Tilly et al.	29
10	Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation	Bone Marrow Transplantation	John Radford, Pam McKay et al.	3
11	Guidelines for the management of diffuse large B‐cell lymphoma	British Journal of Haematology	Sridhar Chaganti, Tim Illidge et al.	113
12	Guidelines for the investigation and management of mantle cell lymphoma	British Journal of Haematology	Pam McKay, Mike Leach et al.	51
13	The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control	Annals of Oncology	S.J. Proctor, Anne Lennard et al.	7
14	Possible significance of cup‐like blasts in acute myeloid leukaemia	British Journal of Haematology	Mike Leach, Pam McKay et al.	5
15	Discriminant analysis of macrocytic red cells	Clinical & Laboratory Haematology	Pam McKay, D. M. Titterington et al.	1
16	CD5 - T lymphocytes in renal transplant recipients	Clinical & Laboratory Haematology	Pam McKay, Anne McLaren et al.	1
17	Primary Cutaneous Diffuse Large B-cell Lymphoma	The American Journal of Surgical Pathology	John R. Goodlad, A S Krajewski et al.	63
18	Primary Cutaneous Follicular Lymphoma	The American Journal of Surgical Pathology	John R. Goodlad, A S Krajewski et al.	70
19	Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation.	PubMed	Pam McKay, S. Cameron et al.	96
20	Should Hyposplenic Patients Receive Prophylaxis against Bacterial Infection?	Scottish Medical Journal	Pam McKay, N.P. Lucie et al.	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact